Nov 9, 2021 Amylyx Pharmaceuticals Announces Results from PEGASUS Trial of AMX0035 in Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference Nov 4, 2021 Amylyx Pharmaceuticals Announces Participants Dosed in the Global Phase 3 PHOENIX Study of AMX0035 in ALS Nov 2...
—initially the fanciful dreams of those seeking a form ofinfiniteintelligence orimmortalitythrough the computerized extension of consciousness—might be used to cure or overcome neurological disorders such asdementia,Alzheimer disease, andparalysis. Likewise, the likely catastrophic effects ofclimate change...
Ginkgo has been much used intraditional Chinese medicine. Toward the end of the 20th century, ginkgo extract became popular in many countries for its purported memory-enhancing properties, and the chemicalconstituentsof the plant are under investigation as a possible treatment forAlzheimer disease. ...